HealthcareServices

Mycoplasma Testing Market Forecast 2026: Where the Industry Is Headed

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the mycoplasma testing market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Mycoplasma Testing Market between 2026 and 2030?

The mycoplasma testing market has witnessed significant expansion in recent years. This market is anticipated to escalate from $1.23 billion in 2025 to $1.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.1%. The historical surge in growth is primarily due to a high prevalence of mycoplasma contamination, increased reliance on cell culture testing, a rise in diagnostic testing demand, the early adoption of PCR methods, and the growing use of ELISA techniques.

The mycoplasma testing market size is anticipated to experience significant expansion over the coming years. By 2030, this market is projected to reach $2.1 billion, demonstrating a compound annual growth rate (CAGR) of 11.1%. This projected growth is driven by several factors including the increasing scale of biopharmaceutical production, the rise in CRO outsourcing activities, greater investment in genomic testing, a heightened regulatory focus on controlling contamination, and the integration of automated testing platforms. Key trends anticipated during this period involve the wider acceptance of pcr-based mycoplasma detection methods, the expanded deployment of rapid test kits for screening cell cultures, an escalating demand for automated mycoplasma detection systems, the broader application of assays and reagents in biopharmaceutical manufacturing, and a greater necessity for mycoplasma testing in both research and CRO environments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Mycoplasma Testing Market?

The growing occurrence of mycoplasma pneumonia is projected to boost expansion within the mycoplasma testing market in the future. This condition is defined as a respiratory infection resulting from the bacterium Mycoplasma pneumoniae. Mycoplasma testing is vital for diagnosing Mycoplasma pneumonia, as it identifies Mycoplasma pneumoniae bacteria in respiratory samples, thereby facilitating prompt and precise infection detection essential for effective medical treatment and management. Illustratively, data from December 2023, provided by the Centers for Disease Control and Prevention, a US-based government agency, indicates approximately 2 million Mycoplasma pneumoniae infections are recorded annually in the United States. Consequently, the rising incidence of mycoplasma pneumonia is a key factor propelling the expansion of the mycoplasma testing market.

How Is The Mycoplasma Testing Market Organized Into Various Segments?

The mycoplasma testing market covered in this report is segmented –

1) By Product: Instruments, Assay, Kits, Reagents

2) By Technology: PCR, Elisa, Enzymatic Methods, DNA Staining, Other Technologies

3) By Application: Cell Line Testing, Virus Testing, End- Of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks And Laboratories, Contract Research Organizations, Academic Research Institutes

Subsegments:

1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment

2) By Assay: Mycoplasma Assays, Qualitative Assays, Quantitative Assays

3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits For Cell Cultures, Sample Preparation Kits

4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents

Which Trends Are Shaping Activity Within The Mycoplasma Testing Market?

Major companies operating in the mycoplasma testing market are increasingly concentrating on introducing digital PCR kits to gain a competitive advantage. Digital PCR kits are sophisticated molecular biology instruments that enable the accurate measurement and examination of nucleic acids, such as DNA or RNA, through a digital methodology. For example, in November 2023, QIAGEN, a diagnostics firm based in Germany, unveiled three new QIAcuity digital PCR kits along with updated software, aiming to expand digital PCR applications in biopharmaceutical studies and food safety. These new QIAcuity kits are engineered for precise quantification and come in one, four, and eight-plate versions; the one-plate version has the capacity to process up to 384 samples within an eight-hour shift. Among these newly introduced kits is the QIAcuity Mycoplasma Quant Kit, which offers researchers a highly accurate and precise solution for identifying mycoplasma contaminants at every stage of their research.

Who Are The Primary Competitors In The Global Mycoplasma Testing Market?

Major companies operating in the mycoplasma testing market are Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Mycoplasma Testing Market?

North America was the largest region in the mycoplasma testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Mycoplasma Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4103&type=smp

Browse Through More Reports Similar to the Global Mycoplasma Testing Market 2026, By The Business Research Company

Immunodiagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

In Vitro Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Immunoglobulin E Ige Allergy Blood Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795